-
EP3868374
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3868374
| EP3868374 - USING FATTY ACID SYNTHASE INHIBITORS TO TREAT FIBROSIS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.09.2022 Database last updated on 24.08.2024 | |
| Former | The application has been published Status updated on 23.07.2021 | Most recent event Tooltip | 16.09.2022 | Application deemed to be withdrawn | published on 19.10.2022 [2022/42] | Applicant(s) | For all designated states Mayo Foundation for Medical Education and Research 200 First Street S.W. Rochester, MN 55905 / US | [2021/34] | Inventor(s) | 01 /
LEOF, Edward B. 4120 Windsor Hills Lane S.W. Rochester, MN Minnesota 55902 / US | 02 /
LUPU, Ruth 2167 Hill Place S.W. Rochester, MN Minnesota 55902-2473 / US | 03 /
KANG, Jeong-Han 6424 Shetland Drive N.W. Rochester, MN Minnesota 55901-5661 / US | 04 /
JUNG, Mi-Yeon 6424 Shetland Drive N.W. Rochester, MN Minnesota 55901-5661 / US | [2021/34] | Representative(s) | Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München / DE | [2021/34] | Application number, filing date | 21150195.2 | 22.03.2017 | [2021/34] | Priority number, date | US201662311615P | 22.03.2016 Original published format: US 201662311615 P | [2021/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP3868374 | Date: | 25.08.2021 | Language: | EN | [2021/34] | Type: | A3 Search report | No.: | EP3868374 | Date: | 10.11.2021 | Language: | EN | [2021/45] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 12.10.2021 | Classification | IPC: | A61K31/365, A61K31/34, A61K31/341, A61K31/713, C12N15/11, A61K48/00, A61K38/00, A61P11/00, A61P43/00 | [2021/34] | CPC: |
A61K31/365 (EP,US);
A61K31/341 (EP,US);
A61K31/713 (EP,US);
A61P11/00 (EP,US);
A61P43/00 (EP,US);
C12N15/1137 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/34] | Title | German: | VERWENDUNG VON FETTSÄURESYNTHASEINHIBITOREN ZUR BEHANDLUNG VON FIBROSE | [2021/34] | English: | USING FATTY ACID SYNTHASE INHIBITORS TO TREAT FIBROSIS | [2021/34] | French: | UTILISATION D'INHIBITEURS D'ACIDE GRAS SYNTHASE POUR TRAITER LA FIBROSE | [2021/34] | Examination procedure | 11.05.2022 | Application deemed to be withdrawn, date of legal effect [2022/42] | 01.06.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2022/42] | Parent application(s) Tooltip | EP17771043.1 / EP3432879 | Fees paid | Renewal fee | 04.05.2021 | Renewal fee patent year 03 | 04.05.2021 | Renewal fee patent year 04 | 31.03.2021 | Renewal fee patent year 05 | 28.03.2022 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2004214804 (GULVE ERIC ARTHUR [US], et al) [X] 1-3 * claims 1, 4-7, 14, 26 *; | [X]US2010190856 (COLOMER BOSCH RAMON [ES], et al) [X] 1-3,5 * paragraphs [0003] , [00 4] , [ 100] *; | [A]US2010197708 (TALLEY JOHN JEFFREY [US], et al) [A] 1-3,5,6* the whole document *; | [X]US2015157634 (BLAZAR BRUCE R [US], et al) [X] 1-3,5 * paragraphs [0020] , [ 167] *; | [X] - JOANA RELAT ET AL, "Different fatty acid metabolism effects of (-)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung ca", BMC CANCER, BIOMED CENTRAL, LONDON, GB, (20120706), vol. 12, no. 1, doi:10.1186/1471-2407-12-280, ISSN 1471-2407, page 280, XP021120446 [X] 1-3,5 * abstract * DOI: http://dx.doi.org/10.1186/1471-2407-12-280 | [X] - CONG CHEN ET AL, "4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic Acid (C75), an Inhibitor of Fatty-acid Synthase, Suppresses the Mitochondrial Fatty Acid Synthesis Pathway and Impairs Mitochondrial Function", JOURNAL OF BIOLOGICAL CHEMISTRY, US, (20140613), vol. 289, no. 24, doi:10.1074/jbc.M114.550806, ISSN 0021-9258, pages 17184 - 17194, XP055521476 [X] 1-3,5 * page 17184 * DOI: http://dx.doi.org/10.1074/jbc.M114.550806 | [A] - CAMELIA R BAN ET AL, "Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers", VASCULAR HEALTH AND RISK MANAGEMENT, NZ, (20080101), vol. 4, no. 3, doi:10.2147/VHRM.S1991, ISSN 1176-6344, pages 575 - 596, XP055521488 [A] 1-3,5,6 * the whole document * DOI: http://dx.doi.org/10.2147/VHRM.S1991 | by applicant | - ANDRIANIFAHANANA et al., FASEB J, (20130000), vol. 27, no. 11, pages 4444 - 54 | - "NCBI", Database accession no. NP _001274689.1 | - JONES et al., Clin Cancer Res, (20150000), vol. 21, no. 24, pages 5434 - 38 | - "GenBank", Database accession no. NP 004095.4 |